JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 45(2011) N 2 p. 300-308;
V.V. Grinev1*, D.V. Posrednik 1, O. Heidenreich2

Effective and Specific Control of aml1/eto Gene Expression in Acute Myeloid Leukemia Cells by Lentivector-Based RNA-Interference

1Department of Genetics, Faculty of Biology, Belarusian State University, Minsk, 22030, Republic of Belarus
2Nothern Institute for Cancer Research at Newcastle University, Newcastle upon Tyne, UK

*grinev_vv@bsu.by
Received - 2010-04-16; Accepted - 2010-09-02

In the presented work, a new approach for the control of aml1/eto gene expression in t(8;21)(q22;q22)-positive acute myeloid leukemia cells has been developed. The technique is based on RNA-interference and lentiviral transduction methodology. Two new lentiviral vector sets for induction of constitutive anti-aml1/eto RNA-interference in acute myeloid leukemia cells have been developed and tested. The first set was based on the use of artificial microRNAs (miRNAs), and the second one was intended for production of short hairpin RNAs (shRNAs). It was shown that Kasumi-1 and SKNO-1 leukemia cells could be efficiently transduced with each new lentiviral vector. Moreover, the percent of modified leukemia cells evaluated in a multiplicity of infection (MOI) test exceeded 90% for Kasumi-1 and SKNO-1 cells at MOI 40 and 20, respectively. Comparative study elucidated that the anti-aml1/eto shRNA-based approach induced a stronger knock-down of aml1/eto gene in Kasumi-1 and SKNO-1 cells compared to the miRNA-based method. We assume that the proposed approach will become a handy tool for regulation of aml1/eto gene expression in both in vitro and in vivo studies of the functional and biological role of the gene.

aml1/eto gene, RNA-interference, lentiviral transduction, leukemia cells, AML1/ETO protein knockdown



JMB-FOOTER RAS-JOURNALS